Jansson, Anna K. http://orcid.org/0000-0001-6305-9729
Söderling, Jonas
Reutfors, Johan
Thor, Anna
Sköld, Camilla http://orcid.org/0000-0001-8212-0003
Cohn-Cedermark, Gabriella
Ståhl, Olof
Smedby, Karin E.
Pettersson, Andreas
Glimelius, Ingrid http://orcid.org/0000-0001-6158-3041
Funding for this research was provided by:
Cancerfonden (CAN 19 0123 Pj)
Article History
Received: 2 July 2022
Revised: 16 March 2023
Accepted: 23 March 2023
First Online: 24 April 2023
Competing interests
: IG participate in educational meetings in collaboration with Jansen-Cilag and with Takeda unrelated to the current work. AP has received honoraria from Capio St Göran, Astellas Pharma and Mediahuset i Göteborg, has been an advisor for Jansen-Cilag, has received grants from Merck & Co, and is the CEO and co-founder of Levo Prevention AB.
: The studies were ethically approved by the Regional Board of the Ethical Committee in Stockholm according to the Declaration of Helsinki (ethical permit number 2016/2562-31/2).